studies in patients with oedema due to congestive heart failure , pulmonary oedema or hepatic disease show that oral or intravenous bumetanide 0.5 to 2 mg/day produces results comparable to those with frusemide 20 to 80 mg/day .
C0013604
oedema
C0016860
frusemide